• Situation Spain suffers twice as much income from Covid as it did a year ago

  • Latest data Madrid continues to lead the infections with 12,894 positives, twice as many as on Tuesday

The next Covid waves will feature the

new variants of the omicron family: BA.4 and BA.5

.

The European Center for Disease Prevention and Control (ECDC) and its American counterpart (CDC)

have focused attention on them in the last week

.

Most EU countries have detected their presence among the population, still low for these new strains, but on the rise in recent weeks.

A clear example is

how it has become the main variant of our Portuguese neighbors.

"There it seems that they have experienced an increase and now they are going down.

The impact has been slight.

We must observe how it has been and take note," explains Antoni Trilla, head of Preventive Medicine at the Hospital Clínic de Barcelona and professor at the University of Barcelona.

In Portugal,

the expansion has been accompanied by an increase in Covid-19 cases

.

For this reason, the ECDC warns that the characteristics found in BA.4 and BA.5 indicate that they will become dominant throughout the continent, which will probably reproduce what happened in the Portuguese country in the coming weeks.

José Antonio López Guerrero, director of the Neurovirology group of the Molecular Biology Department of the Autonomous University of Madrid, explains that

from the ECDC "they are asking the countries to be aware of the data

that are appearing on the new subvariants or lineages".

In addition, he adds that "of the best known variants,

BA.2 is now the predominant one in much of Europe.

The first sub-variants were detected in Africa at the beginning of the year. Everything seems to indicate so far, that like the previous variants ,

the omicron itself, does not increase its virulence

. Which is something that the evolution of viruses does not pursue."

"What if you want to know is why in Portugal it has already reached 87% of the cases.

What is the percentage that BA.4 and, above all, BA.5 already represents in transmission?

", asks López Guerrero.

And in Spain?

On the one hand, Trilla warns that "our neighbors are a few weeks apart and we must observe what is happening there."

On the other hand, López Guerrero stresses that

"in our country we have stopped looking. Practically only those over 60 years of age are monitored.

But what has been seen so far does not constitute a rebound or an outbreak as a result of the appearance of BA .4 and BA.5 as it has been seen in Portugal".

What is the situation in Spain of BA.4 and BA.5?

According to the latest Health report, random screenings using specific PCR for the BA.2 lineage have detected in week 22 of 2022 (May 30 to June 5), percentages that range in the different Autonomous Communities between 55.7% and 91.2%.

That same week,

for lineages BA.4 and BA.5 it is between 5.5% and 44.3%

.

Those with

more than 20% of cases with these lineages are the Balearic Islands, Galicia, Extremadura, Castilla y León and Asturias

.

In Madrid, the Valencian Community, Castilla-La Mancha and Murcia, no specific data has been collected on these lineages.

Some of the communities in which the new faces of SARS-CoV-2 are taking center stage now have a statistically significant upward trend, as pointed out in the latest report from the Carlos III Health Institute.

This occurs in the Balearic Islands and Extremadura.

The Canary Islands, Castilla La Mancha and Madrid also rose in cases, but this cannot be categorically attributed to these new lineages.

By age groups, the increase is important in the group of 80-89 years.

BA.4 and BA.5, more transmissible, how do they evade vaccines?

"

Although apparently they do not produce, a priori, more symptoms, it is true that they have a greater capacity for transmission.

It is even pointed out that they could be less sensitive to immunity to vaccines," says López Guerrero.

This is because

the mutations present in BA.4 and BA.5 represent an important antigenic change (particularly against BA.1)

which could give them a growth advantage thanks to a greater immune escape.

These lineages are considered likely to displace BA.2 in the coming weeks in Europe, hence the warning to EU states about increased surveillance.

However, a study published yesterday in 'Nature' points out how these new variants act and how they dodge defenses created naturally and artificially.

Yunlong Cao's team, lead author of the study and a member of Peking University's Biomedical Pioneering Innovation Center (BIOPIC),

stress that the receptor binding and immune evasion ability of the new variants require immediate investigation.

"Here, along with Spike structural comparisons, we show that BA.2.12.1 and BA.4/BA.5 exhibit ACE2-binding affinities comparable to BA.2.

Importantly, all three variants show neutralization evasion stronger than BA.2

against plasma from three-dose vaccination and, more surprisingly,

against post-vaccination BA.1 infections

."

Trilla clarifies some parts of the study: "It must be taken into account that when they talk about serum protection, they are referring to one of those used in China, Sinovac.

Here in Europe, mRNA vaccines, with which the majority of the population, we know that they are more effective in protection

".

The preventivist also alludes to the fact that

"it is an in vitro, laboratory study."

As Jaime Jesús Pérez, member of the Spanish Association of Vaccinology (AEV), explains, "we must be calm from the point of view that with these new strains we have not seen such a rapid substitution of the existing ones as it went from delta to omicron".

And this has to do with

the fact that "vaccines have demonstrated their effectiveness despite being formulated with the original strain

. Not only with the booster dose, but also with the second dose in the most vulnerable population in the countries that opted for it in spring".

Evasion of natural defenses, getting infected with original omicron and new strains is possible

This comes to put on the table an explanation for the reinfections of

those who were infected in the sixth wave with the 'original' omicron and now, silently, are infected again.

The current data on reinfections in Spain, with the change in surveillance and monitoring, no longer appears in the Renave reports of the ISCIII, it is not known.

Returning to the

Nature

study , Trilla explains that "what is extracted is that these new variants have the ability to do two or three things:

infect people who have already had it previously

, which will

overtake the predominant variants today such as the BA.2

and from a clinical point of view, what we observe

is that they trigger a milder clinical picture

".

And the important thing is that "what is seen in the clinic, in the face offered by the disease caused by BA.4 and BA.5 in the consultation, is the same as what is observed in the laboratory:

the ability to infect or reinfect to people who caught it with BA.1 in December and BA.2 two months ago

. This is that there is a greater ability to avoid the defenses produced naturally by the infection."

López Guerrero insists that "we must remember that

the vaccines are still the same that they gave us against the variants of two years ago

, which no longer exist. So, if this is so, they can

show a greater escape by infecting and reaching more people, this is for pure statistics

", clinches the virologist.

The recipes of the new vaccines, ready to act

This week the EMA announced that the Pfizer-BioNTech and Moderna candidates adapted to the new variants are already in the

rolling review

process .

In other words, they have already provided the necessary documentation so that the agency's technicians give priority to the urgent review of the data for its subsequent approval.

"

It is good news that these times are shortened. In this way at the end of August we could have doses to immunize the population

", explains Pérez.

Conforms to The Trust Project criteria

Know more

  • covid 19

  • Coronavirus

  • Omicron variant

  • Estremadura

  • Portugal

  • Europe

  • Ministry of Defence

  • Canary Islands

  • Murcia

  • Castilla la Mancha

  • Asturias

  • Castile and Leon

  • Galicia

  • Africa

  • CDC

  • Pfizer Vaccine